The Mexican consensus on nonalcoholic fatty liver disease

Rev Gastroenterol Mex (Engl Ed). 2019 Jan-Mar;84(1):69-99. doi: 10.1016/j.rgmx.2018.11.007. Epub 2019 Jan 31.
[Article in English, Spanish]

Abstract

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociación Mexicana de Gastroenterología and the Asociación Mexicana de Hepatología to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathophysiology, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty liver disease.

Keywords: Consenso mexicano; Enfermedad por hígado graso no alcohólico; Mexican consensus; Nonalcoholic fatty liver disease.

Publication types

  • Review

MeSH terms

  • Consensus
  • Disease Progression
  • Humans
  • Mexico
  • Non-alcoholic Fatty Liver Disease / epidemiology
  • Non-alcoholic Fatty Liver Disease / physiopathology
  • Non-alcoholic Fatty Liver Disease / therapy*
  • Prevalence
  • Risk Factors